Neuronetics Launches Postpartum Depression Trial

Neuronetics has enrolled its first five patients in its trial of a transcranial magnetic stimulation device, the NeuroStar TMS, in the hopes that it may treat postpartum depression. The FDA has already approved the device for patients suffering from depression who have not responded to other therapies.
MassDevice